Claudio Maria Mastroianni

Pubblicazioni

Titolo Pubblicato in Anno
Efficacy of antiseptic mouthrinses against SARS-CoV-2: A prospective randomized placebo-controlled pilot study AMERICAN JOURNAL OF OTOLARYNGOLOGY 2022
Evaluation of immunogenicity to three doses of the SARS-CoV-2 BNT162b2 mRNA vaccine in lung transplant patients VACCINES 2022
Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case-control study INFECTION 2022
Evaluation of humoral and cellular response to four vaccines against COVID-19 in different age groups: A longitudinal study FRONTIERS IN IMMUNOLOGY 2022
High frequency of neutralizing antibodies to type I Interferon in HIV-1 patients hospitalized for COVID-19 CLINICAL IMMUNOLOGY 2022
Virological and clinical rebounds of COVID-19 soon after nirmatrelvir/ritonavir discontinuation CLINICAL MICROBIOLOGY AND INFECTION 2022
Longitudinal virological and immunological profile in a case of human monkeypox infection OPEN FORUM INFECTIOUS DISEASES 2022
Quality of t-cell response to sars-cov-2 mrna vaccine in art-treated plwh INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2022
Multiple sclerosis-disease modifying therapies affect humoral and T-cell response to mRNA COVID-19 vaccine FRONTIERS IN IMMUNOLOGY 2022
Prevalence of hepatitis C virus estimates of undiagnosed individuals in different Italian regions. A mathematical modelling approach by route of transmission and fibrosis progression with results up to January 2021 NEW MICROBIOLOGICA 2022
Preferences of PLWH and of clinicians for HIV treatment aimed at long-term success NEW MICROBIOLOGICA 2022
Real life experience on the use of anti-SARS-CoV-2 monoclonal antibodies to prevent COVID-19 progression among inpatients and outpatients: a monocentric experience Abstract book - ICAR 2022 2022
Efficacy of antiseptic mouthrinses against SARS-CoV-2: A prospective randomized placebo-controlled pilot study AMERICAN JOURNAL OF OTOLARYNGOLOGY 2022
Exploiting bacteria for improving hypoxemia of COVID-19 patients BIOMEDICINES 2022
Health-related quality of life in survivors of severe covid-19 infection PHARMACOLOGICAL REPORTS 2022
Evaluation of humoral and cellular response to four vaccines against COVID-19 in different age groups. A longitudinal study FRONTIERS IN IMMUNOLOGY 2022
Clinical Impact of Colonization with Carbapenem-Resistant Gram-Negative Bacteria in Critically Ill Patients Admitted for Severe Trauma PATHOGENS 2022
Challenges in the Clinical Management of {SARS}-{CoV}2-Infected Patients with Haematological Malignancies Social Science Research Network 2022
Quality of T-Cell Response to SARS-CoV-2 mRNA Vaccine in ART-Treated PLWH INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2022
Clinical characteristics and risk factors for mortality in COVID-19 patients during the first wave of the COVID-19 pandemic in Rome, Italy: a single-center retrospective study LE INFEZIONI IN MEDICINA 2022

ERC

  • LS6
  • LS6_6
  • LS6_8
  • LS6_9
  • LS6_11

KET

  • Life-science technologies & biotechnologies

Interessi di ricerca

Infezione da HIV, Tubercolosi, Infezioni del SNC, COVID-19, Terapie innovative delle malattie infettive, antimicrobico resistenza, Studio delle interazioni tra sistema immunitario e infezioni, Infezioni correlate all'assistenza sanitaria, Patogenesi delle infezioni virali

Keywords

antiretroviral therapy hiv
antimicrobial combinations
2019 novel coronavirus
tuberculosis
Bacterial Infections
innate immunity
antimicrobial resistance

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma